CTRI/2024/02/062184Not yet recruitingPhase 4
Comparative efficacy of mycophenolate mofetil and clobetasol propionate for the treatment of oral erosive lichen planus - nil
Dr L Krishna Prasad0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Subjects clinically diagnosed with oral erosive lichen planus.
Exclusion Criteria
- •1.Lichen planus associated with amalgam restorations.
- •2.Asymptomatic oral lichen planus.
- •3.Subjects with uncontrolled diabetes.
- •4.Subjects with pregnancy and lactating mothers
Investigators
Similar Trials
Not yet recruiting
Phase 4
Study comparing the ability of two medications, namely oral tablets of mycophenolate mofetil and cyclophosphamide, in keeping disease well controlled in patients with frequently relapsing or steroid dependent nephrotic syndromeCTRI/2022/10/046891AIIMS New Delhi
Completed
Phase 3
Evaluation of mycophenolate mofetil and prednisolone effect as initial treatment on idiopathic membranous nephropathyChronic nephritic syndrome.Chronic nephritic syndromeIRCT20180128038539N1Ahvaz University of Medical Sciences30
Recruiting
Phase 3
Which drug is better in Takayasu arteritis- Mycophenolate Mofetil or Methotrexate?CTRI/2017/10/010069IPCA Laboratories Limited
Recruiting
Phase 2
The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrenceephrotic syndrome.Nephrotic syndromeIRCT20130812014333N113Kermanshah University of Medical Sciences12
Completed
Not Applicable
Safety and efficacy of mycophenolate mofetil in pediatric renal transplantatioISRCTN89278733Erasmus Medical Center (The Netherlands)44